Biotech CEO, chief physician and Ascendis manager take new company public
About a year after its founding, Danish diagnostics company Fluoguide goes public with a product illuminating cancer cells. The company and its board are led by prominent names in the industry.
In just about a year, new Danish diagnostics company Fluoguide has established a strong organization and is ready for carrying out an IPO in Sweden to raise DKK 16 million (USD 2.42 million) for phase I studies.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
